These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6115442)

  • 1. Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat.
    Dahl SG; Hall H
    Psychopharmacology (Berl); 1981; 74(2):101-4. PubMed ID: 6115442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding.
    Hals PA; Hall H; Dahl SG
    Eur J Pharmacol; 1986 Jun; 125(3):373-81. PubMed ID: 2874041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-apomorphine effects of phenothiazine drug metabolites.
    Morel E; Lloyd KG; Dahl SG
    Psychopharmacology (Berl); 1987; 92(1):68-72. PubMed ID: 2885882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
    Bylund DB
    J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and first-pass metabolism of levomepromazine in the rat.
    Hals PA; Dahl SG
    Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):148-54. PubMed ID: 7072505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites.
    Hals PA; Hall H; Dahl SG
    Life Sci; 1988; 43(5):405-12. PubMed ID: 2899826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of presynaptic dopamine receptors by phenothiazine drug metabolites.
    Nowak JZ; Arbilla S; Dahl SG; Langer SZ
    Life Sci; 1990; 46(6):443-51. PubMed ID: 2304380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding.
    Dahl SG; Hough E; Hals PA
    Biochem Pharmacol; 1986 Apr; 35(8):1263-9. PubMed ID: 2870716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.
    Titeler M; Seeman P
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2249-53. PubMed ID: 27786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain alpha-adrenergic receptors: comparison of [3H]WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex.
    Davis JN; Arnett CD; Hoyler E; Stalvey LP; Daly JW; Skolnick P
    Brain Res; 1978 Dec; 159(1):125-35. PubMed ID: 31963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of dopamine and alpha-adrenergic receptors in human prolactin-secreting adenomas with [3H]-dihydroergocryptine.
    Ramsdell JS; Bethea CL; Jaffe RB; Wilson CB; Weiner RI
    Neuroendocrinology; 1985 Jun; 40(6):518-25. PubMed ID: 2861582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.
    Dahl SG; Hjorth M; Hough E
    Mol Pharmacol; 1982 Mar; 21(2):409-14. PubMed ID: 6124878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.
    Cohen BM; Lipinski JF
    Life Sci; 1986 Dec; 39(26):2571-80. PubMed ID: 2879204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of fluorocatecholamines to adrenergic and dopaminergic receptors in rat brain membranes.
    Nimit Y; Cantacuzene D; Kirk KL; Creveling CR; Daly JW
    Life Sci; 1980 Oct; 27(17):1577-85. PubMed ID: 6255279
    [No Abstract]   [Full Text] [Related]  

  • 15. Levomepromazine receptor binding profile in human brain--implications for treatment-resistant schizophrenia.
    Lal S; Nair NP; Cecyre D; Quirion R
    Acta Psychiatr Scand; 1993 Jun; 87(6):380-3. PubMed ID: 8395131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on adrenergic and dopaminergic receptor binding in rat brain.
    Misra CH; Shelat HS; Smith RC
    Life Sci; 1980 Aug; 27(6):521-6. PubMed ID: 6251333
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha 1 and alpha 2 Adrenergic receptors in mouse brain astrocytes from primary cultures.
    Ebersolt C; Perez M; Bockaert J
    J Neurosci Res; 1981; 6(5):643-52. PubMed ID: 6119369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Methylepinephrine, a methyldopa metabolite that binds to alpha-receptors in rat brain.
    Goldberg MR; Gerkens JF; Oates JA; Robertson D
    Eur J Pharmacol; 1981 Jan; 69(1):95-9. PubMed ID: 6258943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and erythrocyte levels of methotrimeprazine and two of its nonpolar metabolites in psychiatric patients.
    Dahl SG; Bratlid T; Lingjaerde O
    Ther Drug Monit; 1982; 4(1):81-7. PubMed ID: 7071908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.